-TAHO Pharmaceuticals informa de resultados positivos del estudio fundamental de TAH3311, el primer anticoagulante en pelÃcula de disolución oral TAIPEI, 17 de febrero de 2025 /PRNewswire/ — TAHO Pharmaceuticals anuncia resultados preliminares positivos del estudio fundamental de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.